Advertisement mid banner S-Tech 1
Advertisement: Bar Ellison mid banner property
Advertisement: CJBS mid banner
Cambridgeand mid banner advertisement
Advertisement: Kao Data Centre mid banner
Advertisement: RSM mid banner
ARM Innovation Hub
Advertisement: partnersand mid banner
Advertisement: Excalibur Healthcare mid banner
Barr Ellison Solicitors – commercial property
Advertisement: HCR Hewitsons mid banner
Advertisement: Mogrify mid banner
Advertisement: Simpsons Creative
Advertisement: SATAVIA mid banner
Mid banner advertisement: BDO
Advertisement: EBCam mid banner
Advertisement: Cambridge Network mid banner
3 March, 2015 - 09:23 By Kate Sweeney

AstraZeneca and Judge launch school for biotech startups

Christoph Loch, director of Cambridge Judge Business School

AstraZeneca and Cambridge Judge Business School have joined forces to deliver a new Accelerate Cambridge Life Sciences programme that will identify, train and mentor startup ventures in the life sciences.

The partnership underlines the commitment of both AstraZeneca and Judge  to scientific enterprise and innovation in the Cambridge area where AstraZeneca is building a new global R & D centre and corporate headquarters.
Judge, where the programme will be managed, is also in fast growth mode with plans to expand its historic building space. Christoph Loch, director of Cambridge Judge Business School, said: “Inspiring and promoting entrepreneurship form a central part of the Cambridge Judge mission.

“This agreement with AstraZeneca will help a new generation of life science ventures benefit from the rich and varied expertise that Cambridge provides. We are really proud to organise and host the new Accelerate Cambridge Life Sciences programme.”

Menelas Pangalos, executive vice-president of Innovative Medicines & Early Development at AstraZeneca added: “We are proud to be the first life science partner for the Judge Business School’s Cambridge Accelerate Programme.“Having access to support and guidance from experienced AstraZeneca employees will not only be invaluable for the participants as they develop their new ventures but also will be great for our people who will gain exposure to early stage innovation and entrepreneurial thinking outside AstraZeneca.”

The collaboration will begin with a launch workshop at Cambridge Judge on Thursday March 19 examining regulatory, commercial and strategic issues relating to pharmaceutical innovation and development.

A Life Sciences Start-up Weekend over March 20-22 will be attended by biotech entrepreneurs and venture capitalists and will include pitches by startups. Mentoring will be offered to the most promising ventures. The weekly Accelerate Course, due to begin in April, will cover topics ranging from recruiting team members to making the transition from scientist to CEO. 
• For more course information contact //accelerate [at]">accelerate [at]

Newsletter Subscription

Stay informed of the latest news and features